Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|6 Oct 2004||Submitted||Original manuscript|
|29 Nov 2004||Reviewed||Reviewer Report - Avi Ashkenazi|
|5 Dec 2004||Reviewed||Reviewer Report - Alexandru Almasan|
|9 Dec 2004||Author responded||Author comments - Christina Voelkel-Johnson|
|Resubmission - Version 2|
|9 Dec 2004||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|1 Jan 2005||Reviewed||Reviewer Report - Avi Ashkenazi|
|5 Jan 2005||Reviewed||Reviewer Report - Alexandru Almasan|
|6 Jan 2005||Author responded||Author comments - Christina Voelkel-Johnson|
|Resubmission - Version 4|
|6 Jan 2005||Submitted||Manuscript version 4|
|7 Jan 2005||Editorially accepted|
|7 Jan 2005||Article published||10.1186/1471-2407-5-2|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.